NCT04848324 is a NA clinical trial of Corticosteroid Hydrodissection in Carpal Tunnel Syndrome, sponsored by Gaziler Physical Medicine and Rehabilitation Education and Research Hospital.

What drugs are being tested in NCT04848324?

Interventions in NCT04848324: Corticosteroid Hydrodissection, Corticosteroid Injection.

What condition does NCT04848324 study?

NCT04848324 studies Carpal Tunnel Syndrome.

Is NCT04848324 still recruiting?

NCT04848324 is currently completed. Last updated 19 April 2021.

Last reviewed 2021-04-19 · How we verify

NCT04848324

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Short-Term Effectiveness of Ultrasound-Guided Corticosteroid Hydrodissection

Completed NA Last updated 19 April 2021

What this trial tests

NA trial testing Corticosteroid Hydrodissection in Carpal Tunnel Syndrome in 28 participants. Completed in 30 July 2020.

Timeline

1 December 2018

Primary endpoint
30 July 2020

30 July 2020

Quick facts

Lead sponsor	Gaziler Physical Medicine and Rehabilitation Education and Research Hospital
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	non randomized
Design	sequential
Masking	none
Primary purpose	treatment
Enrollment	28
Start date	1 December 2018
Primary completion	30 July 2020
Estimated completion	30 July 2020
Sites	1 location across Turkey (Türkiye)

Drugs / interventions tested

Corticosteroid Hydrodissection
Corticosteroid Injection

Conditions studied

Carpal Tunnel Syndrome — all drugs for Carpal Tunnel Syndrome →

Sponsor

Gaziler Physical Medicine and Rehabilitation Education and Research Hospital

Who can join

Adults 18 to 65, any sex, with Carpal Tunnel Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Aim: Steroid injections are remarkably effective as a treatment for carpal tunnel syndrome (CTS) in the short term. The aim of this study was to determine whether hydrodissection would provide an additional clinical effect when used along with a corticosteroid in the short term. Methods: A prospective cohort of patients with CTS were retrospectively evaluated. 28 patients were selected randomly who received ultrasound (US)-guided triamcinolone hydrodissection (3 mL) as intervention group and received US-guided triamcinolone injection (1 mL) as control group, from the data (case-control ratio 1:1). Outcome measures were the Boston Carpal Tunnel Questionnaire (BCTQ), hand grip strength (HGS), fhe cross-sectional area (CSA) of the median nerve and Short Form 12 (SF-12). Assessments were recorded at baseline, 1 and 4 weeks after injection.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Carpal Tunnel Syndrome

Currently open trials in the same condition.

NCT07312123 — A Study to See Whether Taking a Mix of Vitamins Can Help Adults Recover Better After Surgery for Carpal Tunnel Syndrome · NA · recruiting
NCT07334964 — Ultrasound-Guided Carpal Tunnel Infiltration: Comparison Between the Manual Method and a Robot-Assisted Method · NA · recruiting
NCT07414069 — High-Intensity Laser Therapy in Carpal Tunnel Syndrome: Clinical, Sonographic, and Electrophysiological Outcomes · NA · recruiting
NCT07114913 — Symptom Distribution and Pain Sensitization in Carpal Tunnel Syndrome · recruiting
NCT06905769 — Effects of Aquatic Therapy Versus Neuro-dynamic Technique for the Treatment of Carpal Tunnel Syndrome Patient · NA · active not recruiting

Other Gaziler Physical Medicine and Rehabilitation Education and Research Hospital trials

Trials by the same sponsor.

NCT07207694 — WhatsApp-Based Education Program for Stroke Patients · NA · not yet recruiting
NCT07472543 — Impact of Virtual Reality (VR) Based Exercises on Lower Limb Lymphedema Outcomes (LELO) · NA · recruiting
NCT07507357 — Tidal Model Nursing for TBI Caregivers · NA · completed
NCT07059468 — Osteoporosis After Stroke · completed
NCT06917027 — Comparison of Mobile Education and Face-to-Face Intermittent Catheterization Education · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04848324 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Gaziler Physical Medicine and Rehabilitation Education and Research Hospital
Last refreshed: 19 April 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04848324.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing